Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

What Washington musician Yoko Sen describes as the "soundtrack of her life" is not one of the songs she wrote for the band Dust Galaxy, but the alarm of the heart monitor at her hospital bedside. When the U.S.-based Japanese artist fell ill in 2012 and had to spend weeks in hospitals, she found the jarring sounds there detrimental to her healing. "I thought it was torture, the cacophony of alarms, beeps, doors slamming, the squeaking of carts, people screaming." At the time, it wasn't clear if Sen would make a full recovery. She was connected to four different machines, and each emitted a different sound. Her sensitive ears were especially bothered by the constant beeping of her heart monitor. "Sound is largely ignored in healthcare even though the aesthetics of it could have a great impact on our sense of wellbeing and dignity," Sen realized. When Sen recovered, she was determined to follow her new mission: to "humanize" hospital sounds. How does healing sound? Or love? Are there tunes that foster recovery? She founded SenSound in 2015, a social enterprise to reimagine the acoustic environment in hospitals. [The] 41-year-old Sen is addressing a massive, often overlooked problem. On average, a patient endures 135 different alarms each day, hospitals are often louder than a highway during rush hour and sleep deprivation is a common complaint. Many wish for the sounds of nature, the laughter of children, or the voice of a loved one.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection. During settlement discussions, one of the health-care conglomerate's attorneys has told plaintiffs' lawyers that J&J could pursue the bankruptcy plan, which could result in lower payouts for cases that do not settle beforehand. Plaintiffs' lawyers would initially be unable to stop J&J from taking such a step. J&J faces legal actions from tens of thousands of plaintiffs alleging its Baby Powder and other talc products contained asbestos and caused cancer. The plaintiffs include women suffering from ovarian cancer and others battling mesothelioma. Should J&J proceed, plaintiffs who have not settled could find themselves in protracted bankruptcy proceedings with a likely much smaller company. Future payouts to plaintiffs would be dependent on how J&J decides to fund the entity housing its talc liabilities. J&J is now considering using Texas's "divisive merger" law, which allows a company to split into at least two entities. For J&J, that could create a new entity housing talc liabilities that would then file for bankruptcy to halt litigation. The maneuver is known among legal experts as a Texas two-step bankruptcy. A 2018 Reuters investigation found J&J knew for decades that asbestos, a known carcinogen, lurked in its Baby Powder and other cosmetic talc products.

Note: Can we trust this company with vaccines? For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

In the past two years, a new drug policy reform movement called Decriminalize Nature has persuaded local governments in a half dozen municipalities, including Washington, D.C., to decriminalize "plant medicines" such as psilocybin, ayahuasca, iboga and the cactuses that produce mescaline. Last month, the California State Senate passed a bill that would make legal the personal possession, use and "social sharing" of psychedelics, including LSD and MDMA, a.k.a. Ecstasy or Molly. Political opposition to all these measures has been notably thin. Neither party, it seems, has the stomach for persisting in a war that has achieved so little while doing so much damage, especially to communities of color and our civil liberties. But while we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively? In the case of psychedelics, decriminalizing these powerful compounds is only the first step in a process of figuring out how best to safely weave their use into our society. The main model we have for resocializing a formerly illicit drug is the legalization of cannabis, now the new normal in 18 states. The use of psychedelics by Indigenous peoples ... suggests a model we would do well to keep in mind as we figure out how best to handle these substances.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind altering drugs from reliable major media sources.

New fear-based headlines are popping up every day about the SARS-COV-2 delta variant, now the dominant strain in the U.S., with the focus on evidence of its increased transmissibility, questions about its particular ability to "break through" vaccine protection and the impact that the variant may have on a return to school. The public health emergency of the pandemic as we knew it in California has entered a new stage. We are now in a "control" phase in our state. Vaccines provide a force field of immunity in our communities that leave mainly unvaccinated, high-risk individuals (and those without prior COVID-19 infection) vulnerable to serious disease. That number is getting smaller every day ... and the epidemiology is clear that children are not at high-risk for severe disease. There is no evidence that children have served as vectors for transmission of the virus, have worse long-term outcomes or that the delta variant has led to higher rates of hospitalization in children. In fact, we are seeing exactly what we would expect to see with a successful vaccination campaign: As more adults gain immunity, children are protected, too. This is particularly important as plans for school reopening in the fall reach high gear. The negative health and educational impacts of school closures on children are now abundantly clear. The WHO Europe's guidance should be taken to heart by state and local officials here in California: In-person restrictions and school-closure should be a measure of last resort.

Note: California remains on the only U.S. state which requires children to wear masks in school. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

At least 10 out of 26 Indonesian doctors who have died from Covid-19 this month had been fully vaccinated with Sinovac, prompting health experts to consider whether medics should receive alternative doses to boost immunity. Indonesia, which has relied on the Chinese-made vaccine for its health workers, is struggling with a new surge in coronavirus cases. On Monday the country announced 20,694 new infections. In Kudus, a town in central Java, more than 500 medical workers have tested positive for Covid-19 over the last two weeks, including one doctor who died. All were fully vaccinated. The data, released by the risk mitigation team of the Indonesian Medical Association (IMA), adds to questions about the level of protection that Sinovac provides against new, more infectious variants. The vaccine was approved for emergency use this month by the World Health Organization, which said efficacy results showed it prevented symptomatic disease in 51% of those vaccinated, and prevented severe Covid-19 and hospitalisation in 100% of the studied population. However, several countries that have vaccinated a large proportion of their population and used the Chinese-made Sinovac or Sinopharm vaccines as part of their inoculation campaigns have reported recent outbreaks. These include Mongolia, Seychelles, Bahrain and Chile.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

At the bedside of a single Covid-19 patient who's already received the full official treatment protocol and is failing anyway, the decision to administer a drug like ivermectin, or fluvoxamine, or hydroxychloroquine, or any of a dozen other experimental treatments, seems like a no-brainer. Nothing else has worked, the patient is dying, why not? Telescope out a little further, however, and the ivermectin debate becomes more complicated, reaching into a series of thorny controversies, some ridiculous, some quite serious. The ridiculous side involves ... the censorship of ivermectin news. Anyone running a basic internet search on the topic will get a jumble of confusing results. YouTube's policies are beyond uneven. It's been aggressive in taking down videos ... and doling out strikes to independent media figures. Ivermectin has suffered the same fate as thousands of other news topics since Donald Trump first announced his run for the presidency nearly six years ago, cleaved in two to inhabit separate factual universes for left and right audiences. The drug has become a test case for a controversy that's long been building in health care, about how much input patients should have in their own treatment. Should people on their deathbeds be allowed to try anything to save themselves? That seems like an easy question to answer. Should the entire world be allowed to practice self-care on a grand scale? That's a different issue.

Note: Don't miss the entire article to see just how crazy the medical establishment has become in treating COVID. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Since 9/11, four times as many U.S. service members and veterans have died by suicide than have been killed in combat, according to a new report. The research, compiled by the Costs of War Project at Brown University, found an estimated 30,177 active duty personnel and veterans who have served in the military since 9/11 have died by suicide, compared with 7,057 killed in post 9/11 military operations. The figures include all service members, not just those who served in combat during that time. The majority of the deaths are among veterans who account for an estimated 22,261 of the suicides during that period. "The trend is deeply alarming," the report says. "The increasing rates of suicide for both veterans and active duty personnel are outpacing those of the general population, marking a significant shift." The Department of Veterans Affairs releases information on deaths by suicide, but it does not distinguish by conflict. The report's author, Thomas "Ben" Suitt III, took the VA data and estimated the total number of veteran suicides based on their ages and other factors. A total of 5,116 active duty service members have died by suicide since Sept. 11, 2001, the report says. Figures for the National Guard and Reserves are not available for the first 10 years, but from 2011 to 2020 an estimated 1,193 National Guard and 1,607 Reservists have died by suicide. In an interview, Suitt said the number 30,177 is likely well below the actual number of suicides for active duty and veterans.

Note: For more along these lines, see concise summaries of deeply revealing news articles on military corruption and health from reliable major media sources.

No vaccine provides perfect protection, and so-called breakthrough infections after coronavirus vaccination are rare. Federal health officials have told fully vaccinated people they no longer need to wear masks or maintain social distance because they are protected, nor do they need to be tested or quarantine after an exposure, unless they develop symptoms. Now, the Centers for Disease Control and Prevention has stopped investigating breakthrough infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Earlier this year, the agency was monitoring all cases. Through the end of April, when some 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of breakthrough infections from 46 states and territories, a number that was very likely "a substantial undercount," according to a C.D.C. report. On May 1, the agency decided to investigate only the most severe breakthrough infection cases, while still collecting voluntary reports on breakthrough cases from state and local health departments. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases, but only in limited populations, such as health care workers and essential workers, older adults, and residents at long-term care facilities. But even relatively mild cases of Covid-19 can lead to persistent long-term health problems, and it will be difficult to know the full scope without tracking mild infections as well.

Note: This is a convenient way to make it look like case numbers are dropping more than they actually are, which makes the vaccines look more effective than they really are. Learn more on how the CDC is manipulating case figures in this article. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus vaccine from reliable major media sources.

All covid-19 vaccines currently in use in the US are available under emergency access only. None of the covid-19 vaccines in use are actually "approved." Through an emergency access mechanism known as Emergency Use Authorisation (EUA), the products being rolled out still technically remain "investigational." Factsheets distributed to vaccinees are clear: "There is no FDA approved vaccine to prevent covid-19." One key difference between EUA and approval (also called "licensure," and which for vaccines is known as a BLA (Biologics License Application)) was the expected length of follow-up of trial participants. Unlike its clear articulation of two months for an EUA, the FDA has not committed to a clear minimum for approval. Among the six "first in disease" vaccines approved by the FDA since 2006, pre-licensure pivotal trials were a median of 23 months in duration. Duration of protection is not the only question that longer, placebo controlled trials can address. They also address vaccine safety. The BMJ asked Moderna, Pfizer, and Janssen (Johnson and Johnson) what proportion of trial participants were now formally unblinded, and how many originally allocated to placebo have now received a vaccine. Pfizer declined to say, but Moderna announced that "as of April 13, all placebo participants have been offered the Moderna covid-19 vaccine and 98% of those have received the vaccine." In other words, the trial is unblinded, and the placebo group no longer exists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

I am a 13-year-old in seventh grade, and this is what the pandemic has felt like for me. I consider myself one of the lucky ones. I still got to go to school. Still, it felt like nobody was really there. Usually we sat in a dark room with the lights off and the blinds closed, all of us facing some sort of electronic device, procrastinating and not getting our work done. There are no sports teams. No music rehearsals. No drama club. When I'd get home, the first thing I wanted to do is lay down on my bed and just look up at the ceiling. Every single day. I keep saying to myself, "It's OK because next week will be better." But the next week was always the same. Occasionally, I would break down in tears and have to go to the school counsellor. Some of my classmates have done the same. We don't really need to talk to the counsellor, anyway. What we need is to hang out with our friends. The adults don't really understand. Whenever we'd talk, a teacher would tell us we were spreading spit particles across the room, and that could get someone sick. If we stood up, because we've been sitting for five hours straight, a teacher would tell us to sit back down because we weren't socially distancing. We have been told countless times that if we don't socially distance ... and stop doing the things that make us kids, that make us human beings, we will cause harm to others. Now, kids are scared. If they break these rules they feel like murderers, ungrateful people. But while following these rules we are killing ourselves.

Note: Children's hospitals have reported a sharp uptick in mental illness since the pandemic began. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

After 14 years of legal battles, a federal court ordered the Environmental Protection Agency to take actions that will likely force the neurotoxic pesticide chlorpyrifos off the market. The federal agency has for years been considering mounting evidence that links the pesticide to brain damage in children – including loss of IQ, learning difficulties, ADHD, and autism – but, as the court acknowledged, has repeatedly delayed taking action. "Rather than ban the pesticide or reduce the tolerances to levels that the EPA could find were reasonably certain to cause no harm, the EPA sought to evade through delay tactics its plain statutory duty," Judge Jed S. Rakoff wrote in his decision. "During that time, the EPA's egregious delay exposed a generation of American children to unsafe levels of chlorpyrifos," he wrote, and ordered the EPA to issue a final regulation within 60 days. More than 5 million pounds of chlorpyrifos were applied to crops in 2017, according to the most recent data. The EPA was poised to ban chlorpyrifos in 2016, but the Trump EPA changed course. The reversal, made under EPA Administrator Scott Pruitt, has been tied to a $1 million contribution to President Donald Trump's inaugural fund from Dow Chemical Company, now known as Corteva, which was the primary producer of chlorpyrifos. Patti Goldman, an attorney at Earthjustice who has been overseeing the chlorpyrifos litigation since 2014, said the disparity between the science and the EPA's refusal to act reached new heights during the Trump years.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health from reliable major media sources.

Asked about the future of Parkinson's disease in the US, Dr Ray Dorsey says, "We're on the tip of a very, very large iceberg." Dorsey, a neurologist ... believes a Parkinson's epidemic is on the horizon. Parkinson's is already the fastest-growing neurological disorder in the world; in the US, the number of people with Parkinson's has increased 35% the last 10 years, says Dorsey, and "We think over the next 25 years it will double again." Researchers increasingly believe that one factor is environmental exposure to trichloroethylene (TCE), a chemical compound used in industrial degreasing, dry-cleaning and household products such as some shoe polishes and carpet cleaners. To date, the clearest evidence around the risk of TCE to human health is derived from workers who are exposed to the chemical in the work-place. A 2008 peer-reviewed study in the Annals of Neurology, for example, found that TCE is "a risk factor for parkinsonism." And a 2011 study echoed those results, finding "a six-fold increase in the risk of developing Parkinson's in individuals exposed in the workplace to trichloroethylene (TCE)." While some countries heavily regulate TCE (its use is banned in the EU without special authorization) the EPA estimates that 250m lb of the chemical are still used annually in the US. TCE is currently estimated to be present in about 30% of US groundwater. Using activated carbon filtration devices (like Brita filters) can help reduce TCE in drinking water.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

In the summer of 1981, when he was 13, Grant crashed a trail motorbike. Grant hadn't given this childhood memory much thought in the intervening years, but one hot August day ... he suddenly understood it as a clue to his dangerously unhealthy relationship with alcohol. The day before, a team of specialists at the Royal Devon and Exeter hospital had given him an intravenous infusion of ketamine, a dissociative hallucinogen, in common use as an anaesthetic since the 1970s, and more recently one of a group of psychedelic drugs being hailed as a silver bullet in the fight to save our ailing mental health. To date, more than 100 patients with conditions as diverse as depression, PTSD and addiction have been treated in research settings across the UK, using a radical new intervention that combines psychedelic drugs with talking therapy. What was once a fringe research interest has become the foundation of a new kind of healthcare, one that, for the first time in modern psychiatric history, purports to not only treat but actually cure mental ill health. Under its influence, Grant had an out-of-body experience he struggles to put into words. "It was like I was sinking deeper and deeper into myself," he says. "Then I became white… and I left my body. I was up on the ceiling, looking at myself, but I was just this white entity. I felt very serene and humbled; I finally understood my place in the universe, just a white speck of light, I wasn't the centre of everything and that was fine."

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind altering drugs from reliable major media sources.

Massachusetts General Hospital wouldn't seem like a natural fit for a center devoted to mind-altering drugs. But this week, MGH launched the Center for the Neuroscience of Psychedelics to study the potential of psilocybin and other psychoactive drugs to treat conditions such as depression, addiction, trauma, and more. The new center at MGH signifies that the field of psychedelic therapy has arrived. Inspiration came from the search for ways to ease the misery of patients whose mental illness is resistant to traditional treatments. Psychedelics are known to facilitate "plasticity" in the brain, increasing its capacity for change, and [director Jerrold] Rosenbaum said his team wanted to understand how these agents "move the brain to change in a way that can address many of the most anguishing forms of human suffering." The MGH center combines the disciplines of psychiatry, brain imaging, genomic medicine, and chemical biology. Some of the initial work involving patients will use psilocybin and be directed at rumination – the stuck, repetitive thought patterns that underlie several conditions, from addiction to obsessive-compulsive disorder. The future of the center's research is boundless, since psychedelics' role in neuroplasticity and neuritogenesis – the ability to build new synapses – may be useful in palliative care with terminally ill patients as well as in combatting neurodegenerative diseases such as Parkinson's and Alzheimer's.

Note: This article is also available on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.

The new coronavirus variants have raised concerns about whether vaccines will remain effective against this disease. But the vaccines themselves could drive the evolution of more mutants. The virus is always mutating. And if one happens to produce a mutation that makes it less vulnerable to the vaccine, that virus could simply multiply in a vaccinated individual. But even if that happens, that's only one step in the process. If the vaccine keeps virus levels low, even mutated viruses, the infected person won't produce enough to spread to other people. Unfortunately, at the moment, scientists can't answer the most basic questions about this process. How much does the virus actually replicate inside a person who has been vaccinated with either one dose or two? And how effective is that vaccine at limiting infection enough so that the virus levels stay low and prevent the spread to other people? Andrew Read at Penn State University says, whatever the answers may be, vaccine resistance or escape, as it's called, isn't nearly as scary as bacteria becoming resistant to antibiotics. And this evolutionary pressure is present for any vaccine that doesn't completely block infection. Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.

Note: This informative article presents further data that vaccines lead to increased mutation in viruses. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

A little more than a third of nursing home workers have been getting COVID-19 vaccines when the shots are first offered, U.S. health officials said Monday. The Centers for Disease Control and Prevention gave a national accounting of a problem that's been reported anecdotally – many nursing home workers are not getting the shots. The CDC looked at more than 11,000 nursing homes and skilled nursing facilities that had at least one vaccination clinic between the middle of December and the middle of January. The researchers found that while 78% of residents got at least one shot, only 37.5% of staff members did. Data previously showed that people who work in nursing homes and long-term care facilities get flu vaccines at lower rates than other health-care workers. Surveys suggest that long-term care workers are skeptical the shots work and don't think viruses spread easily from them to the people they care for. The CDC released a second report Monday that offered a larger national look at who has been getting the vaccine. The CDC study found that of the people who got at least one shot between mid-December and mid-January, 63% were women, and 55% were age 50 or older.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

On Jan 13, Dr Yvonne Doyle, the medical director at Public Health England (PHE) issued an alarming statement claiming that Britain had reported the highest number of coronavirus deaths on a single day since the pandemic began. She also alleged that there have now been more deaths in the second wave than the first. Dig a little deeper and the narrative that the second wave is more deadly than the first begins to unravel. According to the Continuous Mortality Investigation (CMI) ... there were 72,900 excess deaths from the start of the pandemic in March to the end of December. Some 60,800 of those occurred in the first wave, but just 12,100 in the second. In a bad winter flu season, around 22,000 excess deaths would be expected. It means that, unlike the first wave, many people included in the coronavirus death figures would have been expected to die of other causes in the past few months. The mortality rate in December 2020 was 1,339.8 deaths per 100,000 males, compared with 1,674.7 in December 2003, and 950.4 deaths per 100,000 females, compared with 1,217.4 in December 2003. The ONS estimates that there were 50,882 more deaths in England in 2020, and 71,110 were due to coronavirus. This means that at least 20,000 people who died from coronavirus last year would have been likely to have died from something else. The figure is likely to be higher because many more people have died from the impact of lockdown.

Note: For more, see this article. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Youtube recently banned a video. In the video, Dr. Michael Yeadon said half or even almost all of the tests for COVID are false positives. Youtube banned the video within hours. Perhaps what irked the Big Tech was Yeadon's assertion that the panic over the second or third wave of coronavirus may be unfounded. Yeadon, who had worked as Chief Science Officer for pharmaceutical giant Pfizer for 16 years, went on to say that "this pandemic is fundamentally over." Yeadon argues, citing principles of epidemiology, that a "second wave" of COVID is entirely manufactured. Citing the experience with other recent virus outbreaks - the SARS virus in 2003, and MERS in 2012 - he says that the idea of subsequent waves itself is wrong. Instead, what appears like subsequent waves is actually a single wave occurring in different geographical regions at different points in time. "It is actually multiple single waves affecting geographically distinct populations at different times as the disease spreads. Analyzed individually, each area followed a typical single event," he says about MERS. He gave another blow to the establishment, saying that lockdown did not actually help curb the virus spread. Yeadon cites the now-famous example of Sweden. Covid-19 doomsday preacher Neil Fergusson had said Sweden would see 40,000 deaths by May and 100,000 in later months as it did not lock up people in grids. Yet, Sweden's coronavirus toll is 6,000 as of now.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

A great deal of conflicting information has emerged about the immune response that develops in patients who have recovered from Covid-19. The good news is that we are unlikely to be reinfected with Sars-Cov-2 repeatedly until it eventually wipes us all out. Most of the evidence ... shows that the immune response to this is quite typical for an acute viral infection. Initially, the body ramps up high levels of IgG antibodies, but after the infection is cleared, those antibodies drop to a baseline level, which may be below the limit of detection of some serological tests. Most people who recover from Covid-19 have detectable neutralising antibodies months after infection. This suggests that Sars-Cov-2 infection does produce an immune response that is protective, at least for several months. Furthermore, antibodies are not the only important part of the immune system. T-cells are also a key component to the immune response. They come in two flavours: helper T-cells, which coordinate immune responses and facilitate immunological memory, and killer T-cells, which kill infected cells. Previous studies have shown that Sars-Cov-2 infection induces robust T-cell responses. Interestingly, some people who have never had Covid-19 have memory T-cells from prior common-cold coronavirus infections that cross-react with Sars-Cov-2, suggesting that there may be some existing protection in the population. T-cells alone are unlikely to provide complete immune protection, but they are a key contributor to immune memory.

Note: The author of this article, Angela Rasmussen, is a virologist and affiliate of the Georgetown Center for Global Health Science and Security. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Previous vaccines have taken a decade or more to develop, and more than half of the past 20 years have failed in clinical trials. However, four [COVID-19] vaccine candidates have entered the final phase of clinical trials prior to approval by the Food and Drug Administration. Operation Warp Speed ... organized government agencies and private companies with the goal of developing, manufacturing and distributing hundreds of millions of vaccine doses, with starting doses to be available by early 2021. At the head of the operation is Moncef Slaoui, a Moroccan-born Belgian-American scientist. Operation Warp Speed … has invested in six vaccine candidates (Moderna, Pfizer / BioNTech, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi / GSK) with the hope that at least one ... will prove safe and effective in clinical trials. Four of the six vaccine candidates have already been shown to be safe and effective in the first two test phases, which test whether the vaccinations produce so-called neutralizing antibodies. Serious health problems regularly arise during vaccination attempts. "We know how to distribute vaccines to any location in the US," says Slaoui. "It happens every year for flu and shingles." Tracking systems need to be "incredibly precise" to ensure that patients are each given two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed … has selected medical distributor McKesson and cloud operators Google and Oracle to collect and track vaccine data.

Note: The above article is also available here. Don't miss this excellent article which raises many important questions about this operation. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.